2obu
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:2obu.gif|left|200px]] | [[Image:2obu.gif|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_2obu", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
| - | | | + | or leave the SCENE parameter empty for the default display. |
| - | | | + | --> |
| - | + | {{STRUCTURE_2obu| PDB=2obu | SCENE= }} | |
| - | + | ||
| - | + | ||
| - | }} | + | |
'''Solution structure of GIP in TFE/water''' | '''Solution structure of GIP in TFE/water''' | ||
| Line 19: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
| - | 2OBU is a [[Single protein]] structure | + | 2OBU is a [[Single protein]] structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2OBU OCA]. |
==Reference== | ==Reference== | ||
| Line 28: | Line 25: | ||
[[Category: Hewage, C M.]] | [[Category: Hewage, C M.]] | ||
[[Category: Malthouse, J P.G.]] | [[Category: Malthouse, J P.G.]] | ||
| - | [[Category: | + | [[Category: Diabetes]] |
| - | [[Category: | + | [[Category: Gip]] |
| - | [[Category: | + | [[Category: Helix]] |
| - | [[Category: | + | [[Category: Molecular modelling]] |
| - | [[Category: | + | [[Category: Nmr]] |
| - | [[Category: | + | [[Category: Obesity]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 10:34:25 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 07:34, 4 May 2008
Solution structure of GIP in TFE/water
Overview
Glucose-dependent insulinotropic polypeptide (GIP) is a gastrointestinal incretin hormone, which modulates physiological insulin secretion. Because of its glucose-sensitive insulinotropic activity, there has been a considerable interest in utilizing the hormone as a potential treatment for type 2 diabetes. Structural parameters obtained from NMR spectroscopy combined with molecular modeling techniques play a vital role in the design of new therapeutic drugs. Therefore, to understand the structural requirements for the biological activity of GIP, the solution structure of GIP was investigated by circular dichroism (CD) followed by proton nuclear magnetic resonance (NMR) spectroscopy. CD studies showed an increase in the helical character of the peptide with increasing concentration of trifluoroethanol (TFE) up to 50%. Therefore, the solution structure of GIP in 50% TFE was determined. It was found that there was an alpha-helix between residues 6 and 29, which tends to extend further up to residue 36. The implications of the C-terminal extended helical segment in the inhibitory properties of GIP on gastric acid secretion are discussed. It is shown that the adoption by GIP of an alpha-helical secondary structure is a requirement for its biological activity. Knowledge of the solution structure of GIP will help in the understanding of how the peptide interacts with its receptor and aids in the design of new therapeutic agents useful for the treatment of diabetes.
About this Structure
2OBU is a Single protein structure. Full crystallographic information is available from OCA.
Reference
The bioactive conformation of glucose-dependent insulinotropic polypeptide by NMR and CD spectroscopy., Alana I, Malthouse JP, O'Harte FP, Hewage CM, Proteins. 2007 Jul 1;68(1):92-9. PMID:17393464 Page seeded by OCA on Sun May 4 10:34:25 2008
Categories: Single protein | Alana, I. | Harte, F P.M O. | Hewage, C M. | Malthouse, J P.G. | Diabetes | Gip | Helix | Molecular modelling | Nmr | Obesity
